Drugmaker Allergan has agreed to pay the federal government and several states $13 million to settle whistleblower claims that it provided business consulting and services to doctors as a way of encouraging them to prescribe the company’s eye care products.
The settlement was announced June 29 in a joint statement by Pittsburgh firm Pietragallo Gordon Alfano Bosick & Raspanti and Chicago law firm Goldberg Kohn. U.S. District Judge Mark Kearney issued a subsequent order acknowledging the settlement and dismissing the case.
